Institut Bergonié: Sarcoma trials
The registry lists 23 Sarcoma studies with Institut Bergonié as lead sponsor. 6 are open to participants now and 8 have results posted.
Phase 1 5Phase 2 11Phase 3 1No phase 9(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Effect of Hypnosis in the Management of Anxiety and Chemo-induced Symptoms in Adolescents and Young Adults With Sarcoma or Germ Cell Tumor and in Young Women With Breast CancerRecruitingNCT07614620Not applicable
- Combination of Pembrolizumab and Cabozantinib in Patients With Advanced SarcomasRecruitingNCT05182164Phase 2
- National Clinical and Biological Sarcoma Database : An Initiative of the French Sarcoma GroupRecruitingNCT03978039
- Benefit of Intensified Peri-operative Chemotherapy Within High-risk CINSARC Patients With Resectable Soft-tissue SarcomasRecruitingNCT03805022Phase 3
- A Phase I/II Study of Regorafenib Plus Avelumab in Solid TumorsRecruitingNCT03475953Phase 1/2
- CINSARC Signature and Correlation With Hemotherapy Efficacy in Soft-tissue Sarcomas. A Biomarker Study.RecruitingNCT02789384Not applicable
- A Public Health Intervention Program to Improve the Initial Management of Soft Tissue Sarcomas.CompletedNCT05007639Results posted
- Patterns of Care and Outcomes in METAstatic Soft Tissue SARComaCompletedNCT03977818Results posted
- Trabectedin Combined With Durvalumab in Patients With Advanced Pretreated Soft-tissue Sarcomas and Ovarian Carcinomas.CompletedNCT03085225Phase 1Results posted
- Variability of Definitions for Survival Endpoints and Surrogate Properties for OS in Sarcoma Trials: a Meta-analysisCompletedNCT02873923Results posted
- Expectations and Priorities of Elderly Patients for a First Medical Treatment for CancerCompletedNCT02821793Results posted
- Targeting Microenvironment and Cellular Immunity in Sarcomas Weekly Trabectedin Combined With Metronomic CyclophosphamideCompletedNCT02805725Phase 1/2Results posted
- A Study of Olaparib With Concomitant Radiotherapy in Locally Advanced/Unresectable Soft-tissue SarcomaCompletedNCT02787642Phase 1Results posted
- Combination of MK3475 and Metronomic Cyclophosphamide in Patients With Advanced Sarcomas : Multicentre Phase II TrialCompletedNCT02406781Phase 2Results posted
- Targeting MDMD and PD1 in Tumors With Tertiary Lymphoid StructuresWithdrawnNCT06084689Phase 2
- Neoadjuvant Chemotherapy and Retifanlimab in Patients With Selected Sarcomas (TORNADO)Active, not recruitingNCT04968106Phase 2
- Bintrafusp Alfa and Doxorubicin Hydrochloride in Treating Patients With Advanced SarcomaActive, not recruitingNCT04874311Phase 2
- Targeting ATR in Soft-tissue SarcomasCompletedNCT04807816Phase 2
- Combining Epigenetic And Immune Therapy to Beat Cancer.CompletedNCT04705818Phase 2
- Combination of Nivolumab Plus Relatlimab in Patients With Advanced or Metastatic Soft-tissue Sarcoma: a Proof-of-concept Randomized Phase II StudyCompletedNCT04095208Phase 2
- Prospective Identification of Predictive Biomarkers of Trabectedin Efficacy in Non-L Soft-tissue Sarcoma PatientsCompletedNCT04008238Not applicable
- Impact of Locoregional Treatment of Soft Tissue Sarcoma on Status of Patients Aged 70 Years and OverActive, not recruitingNCT03077178Not applicable
- A Study of Metronomic CP and JX-594 in Patients With Advanced Breast Cancer and Advanced Soft-tissue Sarcoma (METROmaJX)Status unknownNCT02630368Phase 1/2